Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Inova Diagnostics announces CE for Aptiva, a digital multi-analyte system

Inova Diagnostics announces CE for Aptiva, a digital multi-analyte system

Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce CE Marking of its Aptiva® and Aptiva® Celiac Disease IgA and IgG assays. Aptiva is a fully automated digital multi-analyte system that represents the next generation of high-throughput processors for the clinical laboratory.

Aptiva utilizes a particle-based multi-analyte technology (PMAT)

Aptiva addresses many health economic shortcomings in the autoimmune laboratory. Existing systems provide a limited number of analytes that do not reduce the seronegative gap found in many disease states. Beyond the current portfolio of Celiac assays, in the future Aptiva targets seven additional autoimmune disease states and has over 60 analytes in various stages of advanced development. These additional analytes that are in development will help clinicians close the seronegative gap and improve diagnostic confidence.

Aptiva also delivers several economic benefits for the laboratory. The 150-sample rack capacity reduces the number of daily interventions and a 6.5-hour consumable walkaway time delivers new levels of workflow efficiencies. Aptiva uses a particle-based multi-analyte technology (PMAT), that processes multiple analytes simultaneously from a patient sample. PMAT enables Aptiva to deliver up to 720 results per hour using a 12-analyte test cartridge and allows the laboratory to complete its workflow in a single shift.

“I am truly excited about the approval of Aptiva,” commented Dr. Marcos López Hoyos, Head of Immunology Department, Hospital Universitario, Marqués Valdecilla, Cantabria University, Santander, Spain. “It is the fruition of a long-anticipated technology breakthrough and marks a significant step forward to deliver a set of next generation results that will improve the utility of autoimmune diagnostics and provide clinicians reliable test results.”

“Inova Diagnostics is pleased to launch Aptiva in the EU,” said Roger Ingles, Chief Executive Officer of Inova Diagnostics. “Inova Diagnostics has a 33-year history of providing laboratories with innovative products required for autoimmune diagnosis. Aptiva continues this tradition.”

“Aptiva’s broad disease and syndromic-based analyte portfolio is a breakthrough that fundamentally enhances the utility of diagnostic testing in the laboratory,” said Michael Mahler, PhD., Vice President of Research and Development at Inova. “Aptiva will bring efficiency and reliability to the autoimmune laboratory and provide expanded information to clinicians for management of patients with autoimmune diseases.”

 

About Inova Diagnostics

Inova Diagnostics is a privately held company headquartered in San Diego, California, and is a part of Werfen, a global leader in IVD with a long-term commitment to providing innovative solutions for hospitals and clinical laboratories to improve patient care. Inova Diagnostics manufactures IVD systems, reagents for autoimmune disease and is a leader in the development and commercialization of new autoimmune technologies and diagnostic markers.

 

B. Braun Receives FDA Clearance for SpaceStation MRI

 B. Braun Receives FDA Clearance for SpaceStation MRI

B. Braun Medical Inc. , a leader in infusion therapy and pain management, announced that it has received 510(k) clearance from the US FDA for the SpaceStation MRI to allow Space® infusion pumps to continuously deliver medications to patients within the MRI suite.

“This clearance allows us to expand our infusion therapy portfolio by providing seamless infusion management across multiple care settings,” said Jonathan Stapley, Director of Marketing for Infusion Systems at B. Braun Medical. “Our Space Infusion System allows standardization of large volume and syringe pumps on the same workflow with one integration,” Stapley continued.

The SpaceStation MRI is designed to shield Space infusion pumps against 1.5-T and 3.0-T magnetic fields to protect the MR scanner and provide interference-free images. Long infusion lines are no longer needed and hospital-wide Space infusion pumps are now able to safely transition patients into the imaging suite with the SpaceStation MRI.

“Clearance of the SpaceStation MRI represents a significant development for patients and healthcare providers,” said Angela Karpf, MD, Corporate Vice President, Medical Affairs at

B. Braun Medical. “It will allow patients to be safely transitioned into the MRI suite without the interruption of infusion therapy since there is no need to switch to an alternative pump. The versatility of the SpaceStation MRI accommodates adult, pediatric, and neonatal patients.”

Key features of the SpaceStation MRI include:

Each station holds up to 4 Space pumps, including the Infusomat® Space® Large Volume Pump, Perfusor® Space® Syringe Pump, and the Perfusor® PCA Syringe Pump.
Integrated TeslaSpy® continuously monitors magnetic field strength to provide proper placement and positioning of the SpaceStation MRI.
Pump status window allows for visibility of all infusion pumps with a centralized alarm display to continuously monitor the status on all infusions during imaging.
Standard Space infusion lines can be used with the Infusomat Space Large Volume Infusion Pump and non-dedicated disposables are available for the Perfusor Space Syringe Infusion Pump.
Full drug library software available with DoseGuard™ (Dose Error Reduction Software) Drug Library Development Software, powered by FDB Infusion Knowledge™ allowing online collaboration, access to FDB reference materials, and customizable drug hard and soft limits.

B. Braun offers a full-line of infusion pumps, drug library management, dose error reduction, and interoperability software. The company has a space efficient design which safely integrates with major EMR systems, asset tracking devices, alarm management technologies, and follows the IHE PCD standards in communication and integration. Their integration solution has been shown to improve IV pump utilization by 167%, resulting in $1M immediate capital savings through reduced inventory requirements1.

B. Braun’s DoseGuard Software is the only drug library development solution available that fully integrates FDB’s Infusion Knowledge Portal2. This provides robust evidence-based drug limits with frequent content updates, collaborative authoring tools, and companion audit trails that enable site administrator customization of drug library records for streamlined upload and incorporation into smart pump software.

In addition, B. Braun offers DoseTrac® Software that provides real-time data for consistent documentation and recognition of issues that may lead to an adverse event. DoseTrac Software and Analysis Service have helped clients achieve up to 100% DL compliance, up to 99% reduction in alerts and significant reduction in infusion related medication errors3.

About B. Braun

B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.

 

Wenzel Spine Announces Acquisition of Statera Spine

Wenzel Spine Announces Acquisition of Statera Spine

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, announced that it has completed the acquisition of Statera Spine, a pre-operative diagnostics and quantitative data software solution that improves treatment decisions for spine patients.

Statera Spine is a software enabled spine imaging analytics company dedicated to providing easy-to-use solutions that facilitate improved care for patients suffering from chronic and acute spine issues. Standard pre-operative imaging does not allow for consideration of overall spine biomechanics, including sagittal alignment. The ProfileESP (Expanded Spine Parameters Report), VMA (Vertebral Motion Analysis) technology and integrated Surgical Planning Solution will enhance Wenzel’s current spine fusion-related product portfolio by providing vital diagnostic and decision-making tools that are missing from today’s technology.

“Solutions in diagnostics and surgical planning tools play a critical role in the advancement of Wenzel Spine’s total solution offering in minimally invasive surgery,” said Chad Neely, CEO of Wenzel Spine. “We are very excited to have the experience, expertise and dedication of the Statera Spine team as part of Wenzel Spine. The addition of these unique diagnostic and planning solutions complement our existing minimally invasive implant technology and allow us to bring comprehensive solutions to spine surgeons and their patients. By combining diagnostics with our MIS implant portfolio, we can continue to advance minimally invasive spine surgery, while reducing overall cost.”

The new Wenzel Spine Diagnostics service offering will allow physicians to utilize full spine alignment data, plus motion (angulation and translation) and disc height data at each spine level to aid in the decision-making process alongside their patients. The diagnostic service results in standardized, comprehensive spinal motion and alignment data is conveniently packaged in a graphical, easy-to-read report. Profile ESP and VMA are commercially available in the US. The Surgical Planning Solution is planned to be launched and commercially available in the US in early 2021.

About Wenzel Spine, Inc.

Wenzel Spine, Inc. is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. Headquartered in Austin, TX, Wenzel Spine is focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve patient quality of life by designing and producing devices of the highest quality to support our surgeon clients in the care and treatment of their patients.

Change Healthcare Acquires PROMETHEUS Analytics

Change Healthcare Acquires PROMETHEUS Analytics

Change Healthcare announced it has acquired PROMETHEUS Analytics from Altarum. PROMETHEUS Analytics is a leading reimbursement approach based on medical episodes of care, used by payer-provider collaborations nationwide, uniquely providing a fair and realistic blueprint for value-based payments. It includes more than 90 episode of care definitions outlining the entire range of treatment that include all covered services across providers that would typically treat a patient for a single procedure, illness or condition.

This transaction supports Change Healthcare’s commitment to focus on and invest in core aspects of the business to fuel long-term growth, advance innovation and accelerate the industry’s transition to value-based care.

Change Healthcare has a successful history of working with PROMETHEUS Analytics and was one of the first certified partners of the PROMETHEUS Analytics model supporting some of the nation’s largest health plans with their value-based payment programs.

Healthcare organizations use PROMETHEUS Analytics to optimize their provider networks under value-based care reimbursement models. They create unique analytic insights that help improve provider performance and provide consumers more value from their health care experience. PROMETHEUS Analytics is integrated into Change Healthcare’s HealthQX® value-based care platform that enables health plans to optimize payment models, evaluate provider performance, identify care variations, and improve network efficiency.

“By owning and continuing to develop the industry standard, PROMETHEUS Analytics, Change Healthcare will support all PROMETHEUS users across the industry as they explore innovative ways to reduce cost, increase quality and improve outcomes,” said Robert Capobianco, vice president and general manager, Value-Based Payments at Change Healthcare. “We’re excited about expanding the collaboration around PROMETHEUS Analytics industry-wide to accelerate value-based care in commercial, Medicare and Medicaid markets.”

About Change Healthcare

Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation, and accelerating the transformation of the U.S. healthcare system through the power of the Change Healthcare Platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

Healthcare Informatics: The path to precision care

At a glance

  • Artificial intelligence and machine learning technologies will bring data together to make precision medicine possible.
  • Precision care can enable more focus to be placed on the prevention of disease.
  • Patients will have more involvement and choice in their own care pathways.


Precision medicine will enable a patient’s treatment pathway to be tailored to their individual characteristics. Using artificial intelligence and machine learning technologies, clinicians will be able to examine and interrogate only the most relevant data for each patient, enabling individualized treatments and first-time-right diagnosis.

Hear what your peers are saying about the path to precision care

These healthcare IT leaders discuss how new approaches to the prevention of disease will improve the patient journey.

Dr. Ronnie Ptasznik speaks on how precision diagnosis will deliver a personalized
algorithm for each patient

It’s not going to be enough to look at disease that’s present in the body. We’re going to use artificial intelligence and machine learning to see characteristics in the image that the human eye may not be able to see.”

Dr. Ronnie Ptasznik
Chief Medical Information Officer, Monash Health, Australia

Dr. Ronnie Ptasznik discusses how data can provide real clinical decision support 

We’re talking here about building an infrastructure from the ground up that has the ability to connect data points across an individual’s medical history for their immediate bedside benefit.”

Dr. Ronnie Ptasznik
Chief Medical Information Officer, Monash Health, Australia

Mr. Jacques Rossler sees a future where patients have more involvement and choice in their own care

The future of healthcare looks like precision medicine, artificial intelligence, wearables for the patient, more interaction with the patient.”

Mr. Jacques Rossler
Chief Information Officer, UCL Saint-Luc, Belgium


Dr. Jacob Visser discusses the need to focus on prevention as populations age

So, now we are focused on cure, but we should rather focus on prevention of diseases.”

Dr. Jacob Visser
Chief Medical Information Officer, Erasmus Medical Center, The Netherlands.


Dr. Ronnie Ptasznik discusses discusses the benefts of using data in real-time at the point of care

We want the data to be available at our fngertips in real time at the bedside. So when we plan our systems, we have to ensure that we have maximum interoperability.”

Dr. Ronnie Ptasznik
Chief Medical Information Officer, Monash Health, Australia

Healthcare informatics – Illuminate a new path through the care continuum

Learn how Philips helps healthcare IT leaders bring to life their vision of precision care. For more information, Click Here

Where Can I Get the Most Accurate Up-to-Date Nutrition Info?

Where Can I Get the Most Accurate Up-to-Date Nutrition Info?

Being fit and healthy, learning how to cook proper meals, and improving your knowledge on nutrition are all worthy goals to pursue. The problem is that there is always so much misinformation out there that it can be hard to tell what is right and what is wrong.

Nutrition has a lot of information floating around which makes it susceptible to this issue. One source may make a claim while another refutes it, and so on and so forth. When it comes to learning about nutrition, you want credible sources, but not just that, you want up-to-date information too. Here are ways you can find those nutrition facts that are trustworthy.

Medical Journals

Medical journals provide a collection of information from reputable sources, like Phd-educated doctors, and compile the data for easily searchable and readable material. These can range from chemistry papers to short articles on dietary needs. Medical journals represent an excellent source of information for various scientific fields. Nutrition is also a well-studied field which is featured in many medical journals and has some of the best quality information available. The American Journal of Medicine, European Heart Journal, Canadian Medical Association Journal and the Medical Journal of Australia are amongst numerous high-quality journals that have a plethora of information on nutrition and health. Medical journals are a good place to find up-to-date information because they are well maintained and edited based on relevant papers and documents. They maintain rigid standards to assure that readers and researchers are able to find quality data on topics without having to sift through misleading topics and articles.

Dietician/Nutritionists

What better way to find information than going directly to the source. Dieticians and nutritionists are a good primary source because they have extensive formal education in the field of nutrition and dieting. If you visit the site that you want to learn more nutrition info about, you can always check for guest posts from certified nutritionists or cross-reference data. There are a lot of dieticians and nutritionists that are regulars on websites and blogs and they provide good information on products, meal plans, and other tips that can really help you out. While it is important to keep an eye out for the trustworthiness of information on the internet, dieticians and nutritionists are easy to find to make sense of everything you read or see.

Peer-Reviewed Papers

In a similar sense to medical journals, peer-reviewed papers are another good primary source of information on dietary and nutrition. Medical journals compile a wide array of this information but peer-reviewed papers are denser and require much more thorough examination to make sense of. The importance of peer-review for academic standards is that it equates to a paper that has been checked for accurate information and passes the quality check. Peer-reviewed papers are usually in PDF format online and many are free, available for easy access or viewing through college databases and libraries.

Peer-reviewed papers may be harder to understand than a medical journal that helps highlight or extract pertinent information, but they still offer information on nutrition that is accurate. It is useful to note that many papers have been published from years ago so keep an eye out for any that are seemingly out of date, but many have been edited or amended to include more relevant data.

Government Organizations

Not too many people realize how valuable their taxpayer dollars are for finding information through government websites and databases. For nutrition information, there are numerous government organizations that have collected information sources like the ones listed above to make it easier to find what you are looking for. In the U.S., the USDA (U.S. Department of Agriculture) and the FDA (Food and Drug Administration) both have extensive records available online for browsing. Most countries have their domestic government agency that handles matters of nutrition and food information that are widely available for public use and are free of charge. These organizations have everything from information on specific foods, dietary needs, food growing, food handling practices, and issues of public policy regarding food and agriculture.

In today’s well-connected age of the internet, there is never a shortage of information available on just about any subject you can imagine. The problem is that not all of this information is useful or accurate. Finding up-to-date, relevant, and accurate information for a topic like nutrition can be difficult, but the sources listed above can provide you with an expectation of integrity for research on food, drug, and health data.

Could Hemp Plastic Represent the “Miracle Substance” of the Future?

Could Hemp Plastic Represent the "Miracle Substance" of the Future?

We live within what can only be called a disposable society. Since the dawn of mankind, humans have generated significant amounts of waste. This was not necessarily a problem until the Industrial Revolution. As we began to discover new and more durable materials, we failed to recognise the fact that some of these substances would have extremely adverse impacts upon the environment. This was especially relevant when plastic was invented. Plastic represents one of the most profound threats to the planet and thankfully, businesses are beginning to search for healthier alternatives. One material which shows a great deal of promise is hemp. What advantages does hemp have to offer? Let’s take a look at some of the reasons why this plant-based substance could very well begin to replace plastic in the not-so-distant future.

Hemp is Recyclable

Plastic is dangerous due to the fact that is requires more than 1,000 years to break down into its components. However, hemp will decompose in between three to six months. This is beneficial for two reasons. First, it will not have a lasting impact upon the environment. Secondly, hemp can be used as an effective composting material. In other words, it will help to grow other plants.

A Climate-Friendly Substance

Biodegradable hemp plastic is also surprisingly strong. While many believe that the biodegradable aspects of this plant might equate to physical weakness, it is actually up to 2.5 times more durable than standard plastic. This is critical, as hemp can therefore be used in a wider range of applications than would be possible with plastic. From extra-strong shipping containers to everyday water bottles, the universal nature of hemp cannot be denied.

A Financial Paradigm Shift

It is often frustrating to think about how many billions of pounds oil and petrochemical companies have reaped over the years; particularly when we consider that this was at the expense of the environment. Natural hemp can be produced on a local scale as opposed to remaining the property of big businesses alone. This will help to place money back into the pockets of individual growers. Communities and towns can therefore enjoy a sustainable source of income without placing any additional strain upon the environment.

Additional Intrinsic Qualities

Hemp is indeed a miracle material due to its natural qualities. For example, it is highly resistant to mould and bacteria. Hemp is an effective fireproofing material and it is not toxic. These are some of the reasons why we could see the plant being used in a variety of industries including:

  • Roofing
  • Insulation
  • Flooring
  • Shipping

We should also mention that we are only now beginning to appreciate the many advantages that this natural substance has to offer. This is rather ironic, as ancient civilisations were using hemp for centuries. It is therefore time to appreciate that some modern techniques may be more risky than they are worth. In terms of the future, hemp will provide us with a green edge.

Abbott’s 15-Minute COVID-19 Antigen Test Gets Emergency Use Authorization

Abbott's 15-Minute COVID-19 Antigen Test Gets Emergency Use Authorization

Abbott announced that the U.S. FDA has issued EUA for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection. Abbott will sell this test for $5. It is highly portable (about the size of a credit card), affordable and provides results in 15 minutes. BinaxNOW uses proven Abbott lateral flow technology, making it a reliable and familiar format for frequent mass testing through their healthcare provider. With no equipment required, the device will be an important tool to manage risk by quickly identifying infectious people so they don’t spread the disease to others.

Abbott will also launch a complementary mobile app for iPhone and Android devices named NAVICA™. This first-of-its-kind app, available at no charge, will allow people who test negative to display a temporary digital health pass that is renewed each time a person is tested through their healthcare provider together with the date of the test result. Organizations will be able to view and verify the information on a mobile device to facilitate entry into facilities along with hand-washing, social distancing, enhanced cleaning and mask-wearing.

“We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives,” said Robert B. Ford, president and chief executive officer, Abbott. “BinaxNOW and the NAVICA app give us an affordable, easy-to-use, scalable test, and a complementary digital health tool to help us have a bit more normalcy in our daily lives.”

In data submitted to the FDA from a clinical study conducted by Abbott with several leading U.S. research universities, the BinaxNOW COVID-19 Ag Card demonstrated sensitivity of 97.1% (positive percent agreement) and specificity of 98.5% (negative percent agreement) in patients suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.

“The massive scale of this test and app will allow tens of millions of people to have access to rapid and reliable testing,” said Joseph Petrosino, Ph.D., professor and chairman, Molecular Virology and Microbiology, Baylor College of Medicine, whose labs have been leading efforts to provide COVID-19 testing for the college and Harris County. “With lab-based tests, you get excellent sensitivity but might have to wait days or longer to get the results. With a rapid antigen test, you get a result right away, getting infectious people off the streets and into quarantine so they don’t spread the virus.”

Under FDA EUA, the BinaxNOW COVID-19 Ag Card is for use by healthcare professionals and can be used in point-of-care settings that are qualified to have the test performed and are operating under a CLIA (Clinical Laboratory Improvement Amendments) Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Within these settings, the test can be performed by doctors, nurses, school nurses, medical assistants and technicians, pharmacists, employer occupational health specialists, and more with minimal training and a patient prescription.

Our nation’s frontline healthcare workers and clinical laboratory personnel have been under siege since the onset of this pandemic,” said Charles Chiu, M.D., Ph.D., professor of Laboratory Medicine at University of California, San Francisco. “The availability of rapid testing for COVID-19 will help support overburdened laboratories, accelerate turnaround times and greatly expand access to people who need it.”

Currently, AdvaMed (The Advanced Medical Technology Association) estimates that test manufacturers are shipping about 1 million tests per day. Abbott will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October. The company has invested hundreds of millions of dollars since April in two new U.S. facilities to manufacture BinaxNOW at massive scale.

The BinaxNOW COVID-19 Ag Card can be used as a first line of defense to identify people who are currently infected and who should isolate themselves to help prevent the spread of the disease. It is intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.

As a near-person rapid antigen test, BinaxNOW was engineered for point-of-care settings, near-patient, and not for reference labs. Patient samples should be tested immediately and should not be diluted in viral transport media.

NAVICA mobile app will help facilitate return to daily activities
Abbott is also offering a mobile app at no charge that will allow people to display their results obtained through a healthcare provider when entering facilities requiring proof of testing. The NAVICA app is optional and an easy-to-use tool that allows people to store, access and display their results with organizations that accept the results so people can move about with greater confidence. The app is supported by Apple and Android digital wallets and will be available from public app stores in the U.S.

“While BinaxNOW is the hardware that makes knowing your COVID-19 status possible, the NAVICA app is the digital network that allows people to share that information with those who need to know,” said Ford. We’re taking our know-how from our digitally-connected medical devices and applying it to our diagnostics at a time when people expect their health information to be digital and readily accessible.

If test results are negative, the app will display a digital health pass via a QR code, similar to an airline boarding pass. If test results are positive, people receive a message to quarantine and talk to their doctor. As they’re required to do for all COVID-19 tests, healthcare providers in all settings will be required to report positive results to the CDC and other public health authorities, regardless of whether they use the app. The digital health pass is stored in the app temporarily and expires after the time period specified by organizations that accept the app.

The app’s user interface is supported by a back-end digital infrastructure that is cloud-based, scalable and secure. It’s been designed to support a very large number of users and enable access from anywhere. The app is not for contact tracing and only collects a person’s first and last name, email address, phone number, zip code, date of birth and test results.

About the BinaxNOW COVID-19 Ag Card Test
The BinaxNOW COVID-19 Ag Card is an assay for the qualitative detection of specific antigens to COVID-19 in the human nasal cavity. A simple nasal swab is used to collect specimens from people suspected of having an active infection. No equipment is required to process samples or read test results. In addition, minimal chemical reagents are required, which lessens exposure to biohazardous materials and improves safety for those administering the test.

The BinaxNOW COVID-19 Ag Card is the sixth test that Abbott is launching in the U.S. to help fight the coronavirus pandemic. Abbott’s tests are performed on its high-volume m2000™ and Alinity® m molecular laboratory systems; its ID NOW™ rapid molecular point-of-care platform; antibody tests for its high-throughput ARCHITECT® i1000SR and i2000SR and Alinity™ i laboratory instruments.

Abbott has provided more than 27 million COVID-19 tests in the U.S. to date, including 14 million detection tests and 13 million antibody tests.

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

The BinaxNOW™ COVID-19 Ag Test Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories and patient care settings. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Omnicell secures new partnership with state-of-the-art healthcare facility in Saudi Arabia

Range of in-patient systems will support Iman Abdulrahman Bin Faisal University Hospital to lead the way in Kingdom’s healthcare infrastructure transformation

Omnicell Inc, a leading provider of supply and medication management solutions and adherence tools for healthcare systems and pharmacies and its partner Gulf Medical, has announced a new partnership with Imam Abdulrahman Bin Faisal University Hospital in Eastern Province, Saudi Arabia. Omnicell solutions are set to manage Inpatient Pharmacy Automation throughout the facility. This will support the hospital’s drive to embrace world-class healthcare digitization in line with the Kingdom’s Vision 2030, while further extending Omnicell’s provision of medication management expertise in the region.

Iman Abdulrahman Bin Faisal University Hospital, a new 500-bed education healthcare facility, is due to open in early 2021. As part of its integrated strategy to set new standards in healthcare services, the hospital will incorporate the following portfolio of automation solutions from Omnicell:

  • Automated Dispensing Cabinets – to enable smarter and safer medication management
  • Controlled Substance Dispenser – to increase control and security of controlled substances, high-risk and high-value medications
  • Anaesthesia Workstation – to enable anaesthesia providers instant access to medications and tighter control in the operating room
  • Anywhere RN Software – a mobile medication station which allows nurses remote access to medication management
  • Unity Platform – a comprehensive inventory management system for the supply and dispensing of medication via a single, shared database

These solutions will support pharmacists by automating and scheduling tasks related to medication preparation and distribution. It will reduce the burden on wider healthcare teams by ensuring they provide the right medication, of the right dose, at the right time.

Dr Abdul Salam Al-Asseri, associate professor and chief of pharmaceutical care services at Imam Abdulrahman Bin Faisal University Hospital, says: “With the dynamic advances in pharmacy practice, and with the shift in focus to patient-centred care, automation has become integral in the workplace as it will spare more time for pharmacists to spend on counselling and other patient services. It is always my priority to ensure optimum patient outcomes in an efficient manner. As such partnering with Omnicell will provide a large scale of automated solutions which can help our pharmacists to focus more on patient care and to be deeply involved with the clinicians on the floor. My administration and I look forward to investing in this partnership as the hospital prepares to open its doors for the first time early next year.”

Ivor Matthews, Omnicell Sales Director International – Indirect Markets, adds: “Our solutions significantly reduce the potential for errors and minimise the administrative burden on healthcare professionals, freeing them up to spend more time on face-to-face patient care. Both Omnicell and our partner Gulf Medical are thrilled to join forces with Imam Abdulrahman Bin Faisal University Hospital and support its commitment to healthcare digitization, as set out in the Kingdom of Saudi Arabia’s Vision 2030.”

A spokesman from Gulf Medical commented: “Since Gulf Medical Company started in 1983, the main vision was to bring the most innovative and state-of-the-art medical technology to the Kingdom of Saudi Arabia and the Gulf. Today, after more than three decades, that vision not only lives on but also continues to gain momentum. Thanks to our partner Imam Abdulrahman Bin Faisal University Hospital and Omnicell who contributed with precision and excellence to enrich this vision.”

Omnicell technology has been supporting healthcare providers in the Middle East for 17 years, including King Faisal Specialist Hospital (KSA), National Guard Health Affairs (KSA) and Dubai Health Authority (UAE). Its proven and streamlined range of products and services aim to reduce medication dispensing errors, improve patient safety, drive efficiency and allow healthcare professionals to spend more time on face-to-face patient care.

Omnicell will begin to set-up and implement its systems within Iman Abdulrahman Bin Faisal University Hospital over the next few months, supported by a comprehensive program of staff training, ready for the hospital’s opening in early 2021.

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 6,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell’s innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

Tenet Health Central Coast Announces Safe, Virtual Visits to Emergency Departments Via Tele-ER Option

Tenet Health Central CoastAnnounces Safe, Virtual Visitsto Emergency Departments Via Tele-EROption

Tenet Health Central Coast is announcing this week a new option for patients unsure of whether to come to the emergency room: Tele-ER. This option allows any one to talk to a board-certified Emergency Room physician24 hours a day, seven days a week. All you need is a smart phone, tablet or computer.

“This is a significant achievement in providing patient-first care in the age of the COVID-19 pandemic,” said Tenet Health Central Coast, Chief Executive Officer Mark Lisa. “Tele-ER provides another solution for families and front-line healthcare workers, in addition to our hospitals’ separate COVID SAFE and COVID CARE zones. This is one more way we’re working to keep hospitals operating as efficiently as possible in a rapidly changing environment.

”Patients who may be uncertain whether to seek treatment–either due to suspected COVID-19 or other emergent medical conditions–no longer have to make the decision alone thanks to Tele-ER.

“This helps address a tremendous challenge during these times: across the country, we have seen patients delay care due to concerns about going to hospitals and, unfortunately, that has life-altering consequences,” said Brad Knox, MD, Director of Emergency Services at Tenet Health Central Coast’s Sierra Vista Regional Medical Center, San Luis Obispo County’s only designated Trauma Center.

Cinnamon Redd, MD, the Director of Emergency Services at Twin Cities Community Hospital, which is San Luis Obispo County’s busiest Emergency Department, adds, “the great advantage of Tele-ER is that it provides immediate access for patients and, many times,we will have already seen them virtually if they need to come in-person to the Emergency Department.”Patients can easily access Tele-ERby calling (805) 546-7990at any hour of the day or night.They will connect with a Tenet Health Central Coast Tele-ER staff member to register and get started with a secure, private and individualized ER evaluation. All the patient needs is an internet-connected smartphone, tablet or computer, with a functioning camera.

Due to the need for healthcare options in the face of COVID-19, Medicare now covers Tele-ER visits. The virtual visit cost is typically $20 for Medicare patients, which does not include any follow-up in-person care needed. Tele-ER may be eligible for reimbursement from other insurance providers.

If a patient requires in-person care, diagnostic procedures or lab tests, they will be asked to come into the hospital.Tele-ERis an evaluation tool for patients seeking emergent care and is not a substitute for calling 9-1-1:
if a person’s condition worsens quickly or requires immediate attention, they will be directed to hang up and call 9-1-1 or go to the nearest Emergency Department.

“Peace of mind is an important part of a sound body, and providing our Tele-ER option is yet another way Tenet Health Central Coast helps reinforce the community’s confidence in accessing safe and high-quality care in our hospitals and via virtual visits, whichever is most appropriate,”said Lisa.

About Tenet Health Central Coast
Tenet Health Central Coast is an integrated healthcare system consisting of two acute care hospitals and several affiliated entities, including primary and specialty care, urgent care, outpatient imaging and laboratories across the Central Coast. The hospitals are Sierra Vista Regional Medical Center, the county’s only designated trauma center, in San Luis Obispo, Calif., and Twin Cities Community Hospital in Templeton, Calif. Among their numerous recognitions for quality and compassion, both are internationally recognized Baby-Friendly birth facilities and both have earned the “LGBTQ Healthcare Equality Leader” designation from the Human Rights Campaign Foundation. Tenet Health Central Coast serves many diverse communities throughout the Central Coast, enabling all that come through its doors have access to quality, coordinated care and advanced specialty services at convenient locations.

 

Translate »